NCT01811953View on ClinicalTrials.gov

Equivalence of Resorption of Empagliflozin/Metformin Administered as Combination Tablet Compared With Empagliflozin/Metformin as Single Tablets Administered Together

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

May 31, 2013

Study Completion Date

May 31, 2013

Conditions
Healthy
Interventions
DRUG

Empagliflozin

medium dose oral administration

DRUG

Metformin

oral administration

DRUG

Empagliflozin

low dose of Empagliflozin oral administration

DRUG

Empagliflozin/Metformin

low dose of Empagliflozin

DRUG

Metformin

oral administration

DRUG

Empagliflozin/Metformin

medium dose of Empagliflozin oral administration

DRUG

Empagliflozin

medium dose oral administration

DRUG

Metformin

oral administration

DRUG

Empagliflozin/Metformin

medium dose of Empagliflozin oral administration

Trial Locations (1)

Unknown

1276.8.1 Boehringer Ingelheim Investigational Site, Biberach

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY